Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors

Maria J Diógenes1, Natália Assaife-Lopes, António Pinto-Duarte

  • 1Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

Hippocampus
|April 11, 2007
PubMed

Insights

Adenosine A(2A) receptor activation potentiates brain-derived neurotrophic factor (BDNF) synaptic actions in young and aged rats. Age-related receptor changes influence BDNF

Area of Science:

  • Neuroscience
  • Neurobiology
  • Synaptic Plasticity

Background:

  • Adenosine A(2A) receptor activation potentiates brain-derived neurotrophic factor (BDNF) synaptic actions in infant rat hippocampus.
  • A(2A)-receptor-mediated actions are more pronounced in older rats, suggesting therapeutic potential for BDNF strategies in aging subjects.

Purpose of the Study:

  • To evaluate the synaptic actions of BDNF and receptor levels (TrkB, adenosine A(2A)) in the hippocampus across different age groups of rats.
  • To investigate age-related variations in BDNF's effects on synaptic transmission.

Main Methods:

  • Electrophysiological recordings of field excitatory postsynaptic potentials (fEPSPs) in rat hippocampal slices.
  • Western blot analysis to determine TrkB receptor density.
  • Ligand binding assays to quantify adenosine A(2A) receptor levels.
  • Administration of BDNF and the A(2A) receptor antagonist ZM 241385.

Main Results:

  • BDNF enhanced synaptic transmission in young adult and aged rats, an effect mediated by adenosine A(2A) receptor activation.
  • BDNF showed minimal effect on synaptic transmission in infant and old adult rats.
  • TrkB receptor levels decreased in old adult and aged rats.
  • Adenosine A(2A) receptor levels increased in the hippocampus of old adult and aged rats.

Conclusions:

  • Age-related alterations in TrkB and adenosine A(2A) receptor densities contribute to non-monotonic variations in BDNF's synaptic actions.
  • Understanding these age-dependent changes is crucial for developing effective BDNF-based therapeutic strategies for cognitive aging.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...